Morphine Added to Ropivacaine for FICB for Postoperative Analgesia

B.P. Koirala Institute of Health Sciences

Status and phase: Completed; Phase 4

Conditions: Postoperative Pain

Treatments: Drug: Ropivacaine, Saline; Drug: Ropivacaine, Morphine

Study type: Interventional

Funder types: Other

Identifiers

NCT03875274

IRC/0832/016

Details and patient eligibility

About

prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB

Enrollment: 70 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients undergoing elective femur surgery under spinal anaesthesia

  • Age group (18-65 years)
  • ASA physical status I and II

Exclusion criteria

• • Not willing to participate in the study

  • Other painful co-morbidities (neuropathies)
  • Allergy or any contraindication to study medication
  • Psychiatric disorder
  • Coagulopathy
  • Infection at the site of the block
  • Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

70 participants in 2 patient groups, including a placebo group

Ropivacaine group

Placebo Comparator group

Description:

Ropivacaine 0.375% 20 ml + Normal saline 2 ml via FICB

Treatment:

Drug: Ropivacaine, Saline

Ropivacaine and morphine group

Experimental group

Description:

Ropivacaine 0.375% 20 ml + Morphine 2 ml via FICB

Treatment:

Drug: Ropivacaine, Morphine